Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-2.44 %
$ 128 M
Market Cap
-2.53
P/E
TCRX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TCRX - TScan Therapeutics, Inc.
135 M
LAST VALUE
-15.50%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR